Related references
Note: Only part of the references are listed.Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
Qian Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2011)
Inhibitory effect and transcriptional impact of berberine and evodiamine on human white preadipocyte differentiation
Yueshan Hu et al.
FITOTERAPIA (2010)
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Hao Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Inhibitory Effects of Coptidis rhizoma and Berberine on Cocaine-induced Sensitization
Bombi Lee et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2009)
Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation
Y. Hu et al.
PHYTOMEDICINE (2009)
The ratio of leptin to adiponectin can be used as an index of insulin resistance
Naohisa Oda et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis
T. McLaugblin et al.
DIABETOLOGIA (2007)
The link between abdominal obesity, metabolic syndrome and cardiovascular disease
S. A. Ritchie et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2007)
Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte
Bong-Hyuk Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2006)
Adipocyte differentiation from the inside out
Evan D. Rosen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Transcriptional control of adipocyte formation
Stephen R. Farmer
CELL METABOLISM (2006)
Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway
Cheng Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states
Yun S. Lee et al.
DIABETES (2006)
Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
ME Trujillo et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Interaction between GATA and the C/EBP family of transcription factors is critical in GATA-mediated suppression of adipocyte differentiation
Q Tong et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The anti-inflammatory potential of berberine in vitro and in vivo
CL Kuo et al.
CANCER LETTERS (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Adipose tissue as an endocrine organ
EE Kershaw et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Inhibition of chemical carcinogenesis by berberine in rats and mice
KV Anis et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2001)
Function of GATA transcription factors in preadipocyte-adipocyte transition
Q Tong et al.
SCIENCE (2000)
Share Paper
